- Mass Casualties
- Natural Disasters
- Financial Crisis
- Food Borne Diseases
- US Recall News
- Class Action Lawsuit
- Recent Outbreaks
- Railroad Law
- Court News
- Legal Insight
- Court Watch
- Supreme Court blocks some redrawn North Carolina districts
- Court: Lawsuit alleging coerced confessions can go to trial
- Thai court drops royal insult charges against academic
- Russia court cancels journalist's deportation to Uzbekistan
- Judge to pick battlefield for court fight over Manson's body
- Court halts execution of Alabama inmate with dementia
- Warrant dropped for professor who spoke Hawaiian in court
- Court rules that Kushner firm must disclose partners' names
- Comedian Artie Lange arrested for skipping court
- Supreme Court declines gay rights work discrimination case
Pound told The Associated Press that Sharapova could face a ban of up to four years unless she can prove mitigating circumstances to explain her positive test for meldonium at the Australian Open in January.
Meldonium, a Latvian-manufactured drug designed to treat heart conditions, was added to the World Anti-Doping Agency's banned list on Jan. 1 after authorities noticed widespread use of the substance among athletes.
In announcing her positive test at a news conference in Los Angeles on Monday, Sharapova said she had been using the drug for 10 years for various medical issues. The five-time Grand Slam champion and world's highest-earning female athlete said she hadn't realized meldonium had been prohibited this year, taking full responsibility for her mistake.
"An athlete at that level has to know that there will be tests, has to know that whatever she or he is taking is not on the list, and it was willful negligence to miss that," Pound said. "She was warned in advance I gather. The WADA publication is out there. She didn't pay any attention to it. The tennis association issued several warnings, none of which she apparently read."
Legal News Media
Legal News is the top headline legal news provider for lawyers and legalprofessionals. Read law articles and breaking news from law firm's across the United States to get the latest updates. We reserve the right, at our discretion, to change, modify, add, or remove portions of the site at any time. Your This site is solely for your personal use. You are, of course, welcome to print or otherwise copy material from this site for your personal use. However, you may not distribute, exchange, modify, sell or transmit anything you copy from this Site, including but not limited to any text, images, audio and video, for any business, commercial or public purpose. Any unauthorized use of the text, images, audio and video may violate copyright laws, trademark laws, the laws of privacy and publicity and civil and criminal statutes.